Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Metin Kurtoglu Insider Profile
4 Followers
Metin Kurtoglu, CTO at Cartesian Therapeutics, holds 62.26K shares in Cartesian Therapeutics (Ticker: RNAC). Most recently, Metin Kurtoglu Sold $4,875 shares of Cartesian Therapeutics on Jan 07, 2025 for an estimated value of 81.78K.
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+9.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
CTO
Roles that Metin Kurtoglu holds in companies
Most Profitable Insider Trade
The most profitable trade made by Metin Kurtoglu
Metin Kurtoglu's Trading History
List of latest transactions for each holding click on a transaction to see Metin Kurtoglu's performance on stock
You May Also Like
Metin Kurtoglu insider profile FAQ
What is the percentage of profitable transactions made by Metin Kurtoglu?
The percentage of profitable transactions made by Metin Kurtoglu is 75%.
What is the average return per transaction made by Metin Kurtoglu?
The average return per transaction made by Metin Kurtoglu is 9.70%.
What stocks does Metin Kurtoglu hold?
Metin Kurtoglu holds: RNAC stocks.
What was Metin Kurtoglu’s latest transaction?
Metin Kurtoglu latest transaction was an Informative Sell of $81.78K.
What was Metin Kurtoglu's most profitable transaction?
Metin Kurtoglu’s most profitable transaction was an Informative Sell of RNAC stock on December 11, 2024. The return on the trade was 29.20%.
What is Metin Kurtoglu's role in Cartesian Therapeutics?
Metin Kurtoglu's role in Cartesian Therapeutics is CTO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.